Clinical trial
Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study…
NCT00365443 · Merck Sharp & Dohme LLC, Industry · Withdrawn
Key facts
| NCT number | NCT00365443 |
|---|---|
| Title | Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003) |
| Official title | Proprietary Information - Exploratory (Non-Confirmatory) Trial |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Condylomata Acuminata |
| Intervention type | Biological |
| Interventions | V502 |
| Enrollment | 0 |
| Start date | Oct 1, 2006 |
| First posted | Aug 17, 2006 |
| Last update posted | Jun 19, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: